BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31745592)

  • 1. Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials.
    Xu Z; Luo F; Wang Y; Zou BS; Man Y; Liu JS; Li H; Arshad B; Li H; Li S; Wei YX; Li HY; Wu KN; Kong LQ
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):61-67. PubMed ID: 31745592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function.
    Schagen SB; Hamburger HL; Muller MJ; Boogerd W; van Dam FS
    J Neurooncol; 2001 Jan; 51(2):159-65. PubMed ID: 11386413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: An electrophysiological study.
    Kam JWY; Brenner CA; Handy TC; Boyd LA; Liu-Ambrose T; Lim HJ; Hayden S; Campbell KL
    Clin Neurophysiol; 2016 Jan; 127(1):369-378. PubMed ID: 25868929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
    Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
    Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients.
    Gregorowitsch ML; Ghedri A; Young-Afat DA; Bijlsma R; Baas IO; van Schaik-van de Mheen C; Agterof MJ; Göker E; Ten Bokkel Huinink D; van den Bongard HJGD; Verkooijen HM;
    Breast Cancer Res Treat; 2019 Jun; 175(2):429-441. PubMed ID: 30746636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the relationship between chemotherapy-induced cognitive impairment and age in patients with breast cancer.
    Liu Z; Han X; Tian C; Chen J; Lei L; Liang Q; Lv X; Tang S; Ning P
    J BUON; 2018; 23(6):1601-1605. PubMed ID: 30610783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of congitive functions in patients post acute lymphoblastic leukemia treatment used P300 event related potential].
    Kroczka S; Steczkowska-Klucznik M; Kaciński M; Skoczeń S
    Przegl Lek; 2006; 63 Suppl 1():4-7. PubMed ID: 17471816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cognitive impairment and mood disorder with event-related potential P300 in patients with cerebral small vessel diseases.
    Wang C; Gao J; Li M; Qi H; Zhao T; Zhang B; Zhou C; Fang S
    Neuro Endocrinol Lett; 2019 Dec; 40(7-8):333-341. PubMed ID: 32305050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between self-reported sleep quality components and cognitive functioning in breast cancer survivors up to 10 years following chemotherapy.
    Henneghan AM; Carter P; Stuifbergan A; Parmelee B; Kesler S
    Psychooncology; 2018 Aug; 27(8):1937-1943. PubMed ID: 29683228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functions of adolescent childhood cancer survivors assessed by event-related potentials.
    Lähteenmäki PM; Holopainen I; Krause CM; Helenius H; Salmi TT; Heikki LA
    Med Pediatr Oncol; 2001 Apr; 36(4):442-50. PubMed ID: 11260567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: a longitudinal study.
    Alhareeri AA; Archer KJ; Fu H; Lyon DE; Elswick RK; Kelly DL; Starkweather AR; Elmore LW; Bokhari YA; Jackson-Cook CK
    Breast Cancer Res; 2020 Dec; 22(1):137. PubMed ID: 33276807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
    Park JH; Bae SH; Jung YS; Jung YM
    J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using event-related potential P300 as an electrophysiological marker for differential diagnosis and to predict the progression of mild cognitive impairment: a meta-analysis.
    Jiang S; Qu C; Wang F; Liu Y; Qiao Z; Qiu X; Yang X; Yang Y
    Neurol Sci; 2015 Jul; 36(7):1105-12. PubMed ID: 25663086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study.
    Vega JN; Albert KM; Mayer IA; Taylor WD; Newhouse PA
    J Cancer Surviv; 2019 Oct; 13(5):673-686. PubMed ID: 31338732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive Effect of Donepezil Treatment on P300 and N200 Subcomponents of Auditory Event-Related Evoked Potentials in Alzheimer Disease Patients.
    Vaitkevičius A; Kaubrys G; Audronytė E
    Med Sci Monit; 2015 Jul; 21():1920-7. PubMed ID: 26138001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel improvement of cognitive functions and P300 latency following donepezil treatment in patients with Alzheimer's disease: a case-control study.
    Chang YS; Chen HL; Hsu CY; Tang SH; Liu CK
    J Clin Neurophysiol; 2014 Feb; 31(1):81-5. PubMed ID: 24492450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating Relationship between Pre- and Post- Chemotherapy Cognitive Performance with Levels of Depression and Anxiety in Breast Cancer Patients: A Cross-Sectional Study.
    Hormozi M; Hashemi SM; Shahraki S
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3831-3837. PubMed ID: 31870129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly.
    Tanriverdi F; Yapislar H; Karaca Z; Unluhizarci K; Suer C; Kelestimur F
    Growth Horm IGF Res; 2009 Feb; 19(1):24-30. PubMed ID: 18567522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [P300 cognitive event-related potentials in the diagnosis and classification of possible Alzheimer-type neurocognitive disorders].
    Montoya-Pedrón A; Ocaña-Montoya CM; Bolaño-Díaz GA
    Rev Neurol; 2020 Jul; 71(1):11-18. PubMed ID: 32583410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.